Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 319

1.

Impact of Antiretroviral Regimens on CSF Viral Escape in a Prospective Multicohort Study of ART-Experienced HIV-1 Infected Adults in the United States.

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D.

Clin Infect Dis. 2018 Apr 3. doi: 10.1093/cid/ciy267. [Epub ahead of print]

PMID:
29617912
2.

Poor Self-efficacy for Healthcare Provider Interactions Among Individuals with HIV-Associated Neurocognitive Disorders.

Morgan EE, Woods SP, Iudicello JE, Grant I, Villalobos J; HIV Neurobehavioral Research Program (HNRP) Group.

J Clin Psychol Med Settings. 2018 Mar 20. doi: 10.1007/s10880-018-9560-0. [Epub ahead of print]

PMID:
29557544
3.

Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.

de Almeida SM, de Pereira AP, Pedroso MLA, Ribeiro CE, Rotta I, Tang B, Umlauf A, Franklin D, Saloner RG, Batista MGR, Letendre S, Heaton RK, Ellis RJ, Cherner M; HNRC Group.

J Neurovirol. 2018 Mar 7. doi: 10.1007/s13365-018-0617-5. [Epub ahead of print]

PMID:
29516346
4.

Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.

Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N; CHARTER Group.

Clin Infect Dis. 2018 Mar 1. doi: 10.1093/cid/ciy170. [Epub ahead of print]

PMID:
29506084
5.

Neprilysin in the cerebrospinal fluid and serum of patients infected with HIV1- subtypes C and B.

de Almeida SM, Tang B, Ribeiro CE, Rotta I, Vaida F, Piovesan M, Batistela Fernandes MS, Letendre S, Potter M, Ellis RJ; HIV Neurobehavioral Research Center (HNRC) Group.

J Acquir Immune Defic Syndr. 2018 Feb 21. doi: 10.1097/QAI.0000000000001666. [Epub ahead of print]

PMID:
29481488
6.

HIV p24 antigen is quantifiable at low concentrations in human cerebrospinal fluid with digital ELISA and is associated with decreased neuropsychological performance.

Anderson AM, Tyor WR, Mulligan MJ, Waldrop-Valverde D, Lennox JL, Letendre SL.

Clin Infect Dis. 2018 Jan 29. doi: 10.1093/cid/ciy056. [Epub ahead of print]

PMID:
29385540
7.

Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS.

Moore DJ, Fazeli PL, Moore RC, Woods SP, Letendre SL, Jeste DV, Grant I; HIV Neurobehavioral Research Program.

AIDS Behav. 2018 May;22(5):1551-1561. doi: 10.1007/s10461-017-2001-5.

PMID:
29264737
8.

Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.

de Almeida SM, Ribeiro CE, Rotta I, Piovesan M, Tang B, Vaida F, Raboni SM, Letendre S, Potter M, Batistela Fernandes MS, Ellis RJ; HIV Neurobehavioral Research Center (HNRC) Group.

J Neurovirol. 2018 Feb;24(1):28-40. doi: 10.1007/s13365-017-0591-3. Epub 2017 Oct 23.

PMID:
29063514
9.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

10.

Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection.

Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, Letendre S, Heaton R, Mayo N; CHARTER group,.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):48-54. doi: 10.1097/QAI.0000000000001466.

PMID:
28797021
11.

Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.

Anderson AM, Schein TN, Kalapila A, Lai L, Waldrop-Valverde D, Moore RC, Franklin D, Letendre SL, Barnum SR.

J Neuroimmunol. 2017 Oct 15;311:35-39. doi: 10.1016/j.jneuroim.2017.07.014. Epub 2017 Jul 23.

PMID:
28774464
12.

Neurocognitive functioning among HIV-positive adults in southern India.

Kamat R, McCutchan A, Kumarasamy N, Marcotte TD, Umlauf A, Selvamuthu P, Meyer R, Letendre S, Heaton R, Bharti AR.

J Neurovirol. 2017 Oct;23(5):750-755. doi: 10.1007/s13365-017-0546-8. Epub 2017 Jul 5.

PMID:
28681344
13.

At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS.

Paolillo EW, Gongvatana A, Umlauf A, Letendre SL, Moore DJ.

Alcohol Clin Exp Res. 2017 Aug;41(8):1518-1525. doi: 10.1111/acer.13433. Epub 2017 Jul 5.

PMID:
28679147
14.

Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.

Lalonde L, Quintana-Bárcena P, Lord A, Bell R, Clément V, Daigneault AM, Legris MÈ, Letendre S, Mouchbahani M, Jouini G, Azar J, Martin É, Berbiche D, Beaulieu S, Beaunoyer S, Bertin É, Bouvrette M, Charbonneau-Séguin N, Desrochers JF, Desforges K, Dumoulin-Charette A, Dupuis S, El Bouchikhi M, Forget R, Guay M, Lemieux JP, Morin-Bélanger C, Noël I, Ricard S, Sauvé P, Ste-Marie Paradis F.

Am J Kidney Dis. 2017 Sep;70(3):386-396. doi: 10.1053/j.ajkd.2017.05.008. Epub 2017 Jun 26.

PMID:
28663062
15.

Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.

Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte T, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, Tharakan R, McArthur JC, Fox H, Haughey NJ.

AIDS. 2017 Jun 19;31(10):1365-1378. doi: 10.1097/QAD.0000000000001503.

PMID:
28574961
16.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

PMID:
28447399
17.

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.

Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, Franklin DR, Kaur H, Iudicello J, Grant I, Kallianpur AR.

Fluids Barriers CNS. 2017 Apr 21;14(1):11. doi: 10.1186/s12987-017-0058-1.

18.

Everyday functional ability in HIV and methamphetamine dependence.

Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W; Translational Methamphetamine AIDS Research Center.

Drug Alcohol Depend. 2017 Jun 1;175:60-66. doi: 10.1016/j.drugalcdep.2017.01.035. Epub 2017 Mar 28.

PMID:
28399475
19.

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.

Mehta SR, Pérez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben JD, Franklin D, Rosario D, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A.

J Neuroinflammation. 2017 Mar 31;14(1):72. doi: 10.1186/s12974-017-0848-z.

20.

Plasma dickkopf-related protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment.

Yu C, Seaton M, Letendre S, Heaton R, Al-Harthi L.

AIDS. 2017 Jun 19;31(10):1379-1385. doi: 10.1097/QAD.0000000000001481.

PMID:
28358733

Supplemental Content

Loading ...
Support Center